Product: Eviti

Filter

Thought Leadership

Product

Organization

Eviti Webinar: Oncology Treatment Validation—What is it and Why is it Important?
Spending on cancer drugs in the United States has now exceeded $56 billion and the median annual cost of a new cancer...
Eviti Connect
Abstract photo with data and digital icons
Top 5 Inefficiencies of Prior Authorizations and how payers can overcome them
Prior Authorizations are designed to ensure that patients receive the right care at the right time, and in the most...
NaviNet Open
The Cost of Cancer Care Blog Header Image
The Cost of Cancer Care: The inevitable rise of patient-centric value-based care
In part two of this four-part series from our webinar “The Evolution of Value-Based Care: A Shift to Patient-Centric Care,”...
Eviti
Eviti Connect
NantHealth’s Cancer Therapy Pre-Authorization Platform Eviti Connect® Starts 2020 Strong with Two Expanded Programs
Continued Relationships with Health Insurers Reflect the Need for High-quality, High-value Care as Cancer Treatments Become Increasingly Complex Culver City,...
Eviti Connect
The cost of cancer care
The Cost of Cancer Care: How payers can better manage out-of-control cancer costs
In 2018, spending on cancer drugs in the United States has more than doubled since 2013 and has now exceeded...
Eviti
Megan Headshot
Employee Spotlight: Megan Salmon-Gardell, RN
Knowledgeable, caring, inspiring, a great leader, and mentor. These are the words used to describe Eviti Senior Director of Clinical...
NantHealth
Eviti Advisor
Eviti Advisor Infographic
Cancer care is costly and complex; and if you don’t have the tools needed to effectively manage your cancer spend,...
Eviti Advisor
Woman researcher looking through a microscope
Eviti® Advisor–Evidence-Based Treatment Intelligence for Improved Outcomes in Oncology
Cancer care is costly and complex; and if you don’t have the tools needed to effectively manage your cancer spend,...
Eviti Advisor
Eviti Connect
NantHealth’s Eviti Connect Data Shows Recycling of Chemotherapy and Biologics for Advanced CRC Patients More Common Than Switching to Drug...
NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium San Francisco, CA – January 25, 2020: NantHealth, Inc....
Eviti Connect
Eviti Connect
The Evolution of Value-Based Care: A Shift to Patient-Centric Care
Learn how payers can curb out-of-control cancer costs and address the inevitable swing to consumer-driven approaches to care. This webcast...
Eviti Connect
Eviti Connect
Panel Discussion: Technology’s Role in Reducing Rising Cancer Care Costs
Innovative new treatments and advanced therapies have provided a fundamental shift in oncology care. This evolution has transformed outcomes for...
Eviti Connect
Eviti Connect
Biosimilars: Fact vs Fiction—Understanding biosimilars and their potential for lowering cancer care costs
Biosimilars are becoming quite the buzzword in cancer treatment, but cost, regulation, safety and efficacy are driving questions amongst payers...
Eviti Connect